Stryker price target raised to $331 from $313 at BTIG

BTIG analyst Ryan Zimmerman raised the firm’s price target on Stryker to $331 from $313 and keeps a Buy rating on the shares. Stryker is set up well in FY23 though and the year will be characterized by the combination of a robust product cadence, improving procedural dynamics, a strong order book, and expense control, putting shares in a position to show upside especially in 2H23 as margins improve, the analyst tells investors in a research note.